These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 6685582

  • 1. Effects of short-term administration of verapamil on left ventricular relaxation and filling dynamics measured by a combined hemodynamic-ultrasonic technique in patients with hypertrophic cardiomyopathy.
    TenCate FJ, Serruys PW, Mey S, Roelandt J.
    Circulation; 1983 Dec; 68(6):1274-9. PubMed ID: 6685582
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Relaxation and regional myocardial stiffness in obstructive hypertrophic cardiopathy patients: effect of verapamil].
    Bonandi L, Hess OM, Grimm J, Krayenbühl HP.
    G Ital Cardiol; 1984 Feb; 14(2):77-84. PubMed ID: 6538857
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe.
    Bonow RO, Ostrow HG, Rosing DR, Cannon RO, Lipson LC, Maron BJ, Kent KM, Bacharach SL, Green MV.
    Circulation; 1983 Nov; 68(5):1062-73. PubMed ID: 6684510
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathy.
    Betocchi S, Piscione F, Losi M A, Pace L, Boccalatte M, Perrone-Filardi P, Cappelli-Bigazzi, Briguori C, Manganelli F, Ciampi Q, Salvatore M, Chiariello M.
    Am J Cardiol; 1996 Aug 15; 78(4):451-7. PubMed ID: 8752192
    [Abstract] [Full Text] [Related]

  • 14. [Effects of verapamil on systolic time intervals and relaxation time in hypertrophic cardiomyopathy (author's transl)].
    Hirose K, Shimada T, Matsumura T, Iwata M, Yasunaga K, Hori K, Matsusaka J.
    J Cardiogr; 1981 Dec 15; 11(4):1223-32. PubMed ID: 7201494
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of verapamil and nifedipine on rate of left ventricular relaxation in coronary arterial disease patients.
    Bolognesi R, Cucchini F, Manca C, Ferrari R.
    Int J Cardiol; 1987 Mar 15; 14(3):333-41. PubMed ID: 3557711
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of calcium-channel blocking agents on left ventricular diastolic function in hypertrophic cardiomyopathy and in coronary artery disease.
    Bonow RO.
    Am J Cardiol; 1985 Jan 25; 55(3):172B-178B. PubMed ID: 3881911
    [Abstract] [Full Text] [Related]

  • 20. Failure of calcium channel blockers to improve ventricular relaxation in humans.
    Nishimura RA, Schwartz RS, Holmes DR, Tajik AJ.
    J Am Coll Cardiol; 1993 Jan 25; 21(1):182-8. PubMed ID: 8417060
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.